Outcomes of Transcatheter Aortic Valve Replacement in Mixed Aortic Valve Disease. Academic Article uri icon

Overview

abstract

  • OBJECTIVES: The aim of this study was to compare outcomes after transcatheter aortic valve replacement (TAVR) in patients with pure aortic stenosis (AS) (i.e., no or trivial associated aortic regurgitation [AR]) with those in patients with AS and mild or more severe AR (i.e., mixed aortic valve disease [MAVD]). BACKGROUND: TAVR is indicated in treating patients with severe AS. Limited data exist regarding the outcomes of TAVR in patients with MAVD. METHODS: A total of 1,133 patients who underwent TAVR between January 2014 and December 2017 were included. The primary outcome was all-cause mortality. The comparison was adjusted to account for post-TAVR AR development in both groups. The secondary outcomes included composite endpoints of early safety and clinical efficacy as specified in the Valve Academic Research Consortium-2 criteria. Variables were compared using Mann-Whitney, chi-square, and Fisher exact tests, while Kaplan-Meier analyses were used to compare survival. RESULTS: A total of 688 patients (61%) had MAVD (median age 83 years , 43% women). Among these, 17% developed mild, 2% moderate, and <1% severe post-TAVR AR. Overall, patients with MAVD had better survival compared with patients with pure AS (p = 0.03). Among patients who developed post-TAVR AR, those in the MAVD group had better survival (p = 0.04). In contrast, in patients who did not develop post-TAVR AR, pre-TAVR AR did not improve survival (p = 0.11). CONCLUSIONS: Patients with MAVD who underwent TAVR had better survival compared with patients with pure AS. This is explained by the better survival of patients with MAVD who developed post-TAVR AR, likely due to left ventricular adaptation to AR.

publication date

  • October 30, 2019

Research

keywords

  • Aortic Valve
  • Aortic Valve Insufficiency
  • Aortic Valve Stenosis
  • Transcatheter Aortic Valve Replacement

Identity

Scopus Document Identifier

  • 85074633246

Digital Object Identifier (DOI)

  • 10.1016/j.jcin.2019.06.020

PubMed ID

  • 31678084

Additional Document Info

volume

  • 12

issue

  • 22